TLPH vs IRWD โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
IRWD Captures Institutional Edge (3โ1 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ironwood Pharmaceuticals, Inc. - Class A (IRWD) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while TLPH counters with relative strength in Valuation. Fundamentally, TLPH trades at 1.0x Forward P/E with -1474700.0% operating margin (+0.0% YoY revenue) versus IRWD at 12.3x Forward P/E and 62.9% operating margin (+9.0% YoY). In options structure, TLPH sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro) against IRWD sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | TLPH | IRWD | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $53.7M | $802.9M | Larger Scale | IRWD |
| Trailing P/E Ratio Valuation | 1.0x | 5.4x | Lower Multiple | TLPH |
| Forward P/E Ratio Valuation | 1.0x | 12.3x | Lower Multiple | TLPH |
| Revenue Growth (YoY) Growth | +0.0% | +9.0% | Higher Growth | IRWD |
| Operating Margin (TTM) Profitability | -1474700.0% | 62.9% | Higher Margin | IRWD |
| Net Profit Margin Profitability | 0.0% | 37.4% | Higher Margin | IRWD |
| Return on Equity (ROE) Capital Efficiency | -143.4% | -574.7% | Higher ROE | TLPH |
| 52-Week Range Position Momentum | 20% ($1โ$2) | 68% ($3โ$6) | Stronger Trend | IRWD |
| Beta / 30D Volatility Risk Regime | 1.11ฮฒ ยท 58% Vol | 1.37ฮฒ ยท 54% Vol | Lower Realized Risk | IRWD |
| Unified Institutional Score Composite Signal | 37.1 / 100 (SELL) | 35.0 / 100 (SELL) | Higher Composite | TLPH |